What’s Driving Pfizer’s Pursuit of AstraZeneca?

April 28 (Bloomberg) -- Bloomberg’s Drew Armstrong examines what Pfizer stands to gain from its $98.7 billion pursuit of AstraZeneca on Bloomberg Television’s “Market Makers.”
Vanity Fair's Carter: I Think There's a Bubble in Tech
21:11 - Graydon Carter, Vanity Fair's editor-in-chief, discusses the tech landscape with Bloomberg's Emily Chang and Brad Stone at the VF New Establishment Summit in San Francisco. (Source: Bloomberg)
  • Sam Altman: Some Late-Stage Startups Are Overpriced
  • Tech Leaders Weigh In on Jack Dorsey
  • Eventbrite CEO: We're Focused on Funding Our Own Growth